Wuhan Healthgen Biotechnology Corp.

Wuhan Healthgen Biotechnology Corp., specializing in molecular pharmaceutical R&D, is focusing on developing, manufacturing, and marketing a series of environmentally friendly and safe products using the State-of-the-Art platform OryzHiExp, which has a high capacity to express proteins or small peptides in rice grains. 
The products include: 
-Recombinant Human Serum Albumin(OsrHSA)
-Recombinant Human Fibronectin(OsrhFN), 
-Recombinant Human Transferrin(OsrhTF) 
-Growth Factors such as Recombinant Human Basic Fibroblast Growth Factor(OsrhbFGF), Recombinant Human Epidermal Growth Factor(rEGF), Recombinant Human Insulin-like Growth Factor LR3(rIGF-1 LR3), Recombinant Human Vascular Endothelial Growth Factor(OsrhVEGF), Recombinant Human Keratinocyte Growth Factor(OsrhKGF).
These products are critical components in cell culture media supplements, cosmetic formulations, and industrial biological reagents, supporting applications across biopharmaceutical manufacturing, life science research, and advanced therapies.